Strategic question
Where are competitors investing and partnering in Digital Health, and what should that mean for our own portfolio strategy?
How Galen Growth helped
From market signal to decision-ready evidence
Powered by HealthTech Alpha, Galen Growth mapped the Digital Health partnerships of the client’s top 25 competitors across 15 countries and two therapeutic areas. We then co-developed a relevance-scoring framework using proprietary venture signals to prioritise the most decision-relevant opportunities.
Outcomes
Clarified where competitors were building capability, where strategic white space existed and which ventures merited closer evaluation against a defensible comparative framework.
Decision enabled: Enabled the client to reprioritise partnership focus and evaluate high-potential ventures against a defensible comparative framework.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Tracking Competitor Moves to Support Global Franchise Strategy
How should we track competitor activity across obesity, diabetes and cardiovascular disease to support global strategic decisions?
Prioritising Markets and Partners to Accelerate a Women’s Health Roadmap
Which priority markets and venture partners should anchor our future women’s health innovation roadmap, starting with telemedicine?
Informing Franchise-Level Resource Allocation Across APAC
Which APAC markets should we prioritise for Digital Health investment, and where is our franchise readiness strongest?